83
57
Growth Score
-6 pts
Heat Score
-5 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
508658
Cyclarity Therapeutics develops drugs to prevent age-related conditions like atherosclerosis, heart attacks, and strokes.
- Michael Kope: Co-Founder and CEOPast Role: SENS Foundation, Founding Chief Executive Officer
- Amelia Anderson: Co-Founder and Head of Scientific Computing
About the Company
Cyclarity Therapeutics develops drugs aimed at preventing common age-related conditions such as atherosclerosis, heart attacks, and strokes. The company focuses on addressing the root causes of these diseases to deliver simple and affordable therapies for cardiovascular and other chronic diseases of aging. Their research and operations are
conducted in state-of-the-art labs, and they have recently completed a Series Seed funding round to further their mission.
